 |
Synthetic human secretin |
|---|---|
| Trade Name | |
| Orphan Indication | For use in conjunction with diagnostic, therapeutic, or combined diagnostic/therapeutic procedures for pancreatic disorders to increase pancreatic fluid secretion |
| USA Market Approval | USA |
| USA Designation Date | 2000-03-07 00:00:00 |
| Sponsor | ChiRhoClin, Inc.;15500 Gallaudet Ave.;Silver Spring, Maryland, 20905 |
